Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Antifibrinolytic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global antifibrinolytic drugs market reached a value of US$ 15.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 20.46 Billion by 2027, exhibiting a CAGR of 4.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Antifibrinolytic drugs refer to the pharmaceutical medicines used for promoting the formation of blood clots to prevent fibrinolysis or blockage in arteries and veins. These drugs inhibit the activation of plasminogen, thereby preventing the lysis of fibrin and maintaining clot stability. They are used for the treatment of hemorrhages, vascular tumors and providing relief from heavy menstrual bleeding. They are also used for controlling bleeding during or after invasive surgeries. Some commonly available antifibrinolytic drugs include tranexamic acid, aprotinin, aminocaproic acid and serine protease inhibitors. They are widely used for the management of mucosal bleeding in the oropharynx, nose, gastrointestinal (GI) tract and uterine-vaginal linings. As a result, they are extensively used across hospitals, clinics and trauma and ambulatory surgical centers.

Antifibrinolytic Drugs Market Trends:

The rising incidence of road accidents, traumas and various bleeding disorders is one of the key factors driving the growth of the market. Moreover, the widespread adoption of antifibrinolytic drugs to prevent blood loss in women suffering from menorrhagia and during cardiovascular and neurosurgeries is providing a thrust to the market growth. Antifibrinolytic drugs are essential for preventing clot lysis and minimizing blood loss. In line with this, increasing health consciousness and awareness among the masses regarding the available treatment alternatives for hereditary angioedema and hemophilia are also contributing to the growth of the market. Various technological advancements and the increasing utilization of antifibrinolytic therapy to reduce transfusion in orthopedic patients are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing innovative oral and intravenous drug variants with enhanced efficacy and bio-absorbability. Other factors, including the rising geriatric population and significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antifibrinolytic drugs market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on indication, form and end user.

Breakup by Indication:

  • Gynecology
  • Hereditary Angioedema
  • Fibrinolytic Response Testing
  • Surgeries
  • Others
     

Breakup by Form:

  • Oral
  • Injectable
     

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ACIC Pharmaceuticals Inc., Akorn Inc., Aurobindo Pharma Limited, Ferring Pharmaceuticals, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Viatris Inc. and Vitruvias Therapeutics Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Indication, Form, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered ACIC Pharmaceuticals Inc., Akorn Inc., Aurobindo Pharma Limited, Ferring Pharmaceuticals, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Viatris Inc. and Vitruvias Therapeutics Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global antifibrinolytic drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global antifibrinolytic drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the form?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global antifibrinolytic drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Antifibrinolytic Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Indication
    6.1    Gynecology
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Hereditary Angioedema
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Fibrinolytic Response Testing
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Surgeries
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Form
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Injectable
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ambulatory Surgical Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Trauma Centers
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    ACIC Pharmaceuticals Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Akorn Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Aurobindo Pharma Limited
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Ferring Pharmaceuticals
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Novartis AG
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Pfizer Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Takeda Pharmaceutical Company Limited
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Viatris Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Vitruvias Therapeutics Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio

List of Figures

Figure 1: Global: Antifibrinolytic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antifibrinolytic Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Antifibrinolytic Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Antifibrinolytic Drugs Market: Breakup by Indication (in %), 2021
Figure 5: Global: Antifibrinolytic Drugs Market: Breakup by Form (in %), 2021
Figure 6: Global: Antifibrinolytic Drugs Market: Breakup by End User (in %), 2021
Figure 7: Global: Antifibrinolytic Drugs Market: Breakup by Region (in %), 2021
Figure 8: Global: Antifibrinolytic Drugs (Gynecology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Antifibrinolytic Drugs (Gynecology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Antifibrinolytic Drugs (Surgeries) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Antifibrinolytic Drugs (Surgeries) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Antifibrinolytic Drugs (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Antifibrinolytic Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Antifibrinolytic Drugs (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Antifibrinolytic Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Antifibrinolytic Drugs (Injectable) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Antifibrinolytic Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Antifibrinolytic Drugs (Trauma Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Antifibrinolytic Drugs (Trauma Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Antifibrinolytic Drugs (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Antifibrinolytic Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Antifibrinolytic Drugs Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Antifibrinolytic Drugs Industry: SWOT Analysis
Figure 80: Global: Antifibrinolytic Drugs Industry: Value Chain Analysis
Figure 81: Global: Antifibrinolytic Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antifibrinolytic Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 3: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Form (in Million US$), 2022-2027
Table 4: Global: Antifibrinolytic Drugs Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Antifibrinolytic Drugs Market: Competitive Structure
Table 7: Global: Antifibrinolytic Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links